CSL (ASX: CSL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
CSL Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
CSL (ASX: CSL)
Latest News
Healthcare Shares
CSL share price 'ticks all the defensive boxes': fundie
Investing Strategies
'Over 100% gain next year': Expert picks 3 best ASX shares for 2023
Healthcare Shares
3 ASX shares to combat the next market dip: experts
How to invest
I'd aim for $1 million in retirement buying just 10 ASX 200 shares
Healthcare Shares
Why this could be a 'powerful driver of sector dominance' for CSL shares: Wilsons
Healthcare Shares
Here's what Citi is saying about the CSL share price
Healthcare Shares
Why did the CSL share price just crack $300 for only the third time in 2022?
Retirement
3 dividend-paying ASX growth shares I would buy to retire rich
Healthcare Shares
4 ASX 200 shares to buy in an unmissable sector: expert
Share Market News
Will ASX 200 shares bottom before the year is out? Here's Macquarie's 'best guess'
Broker Notes
To $300 and beyond! Why this top broker says CSL shares are a buy right now
Blue Chip Shares
Are these the very best ASX 200 shares to buy for 2023?
Frequently Asked Questions
-
CSL was listed on the ASX in June 1994.
-
CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.
Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.
-
CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.
-
CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents.
CSL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About CSL
CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.
CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.
CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).
The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.
